Phyllis Robin Hedge

Title: Phyllis Robin Hedge: Innovator in T Cell Production

Introduction

Phyllis Robin Hedge is a notable inventor based in Cambridge, CA. He has made significant contributions to the field of immunology, particularly in the production of T cells. His innovative methods have the potential to impact various therapeutic and commercial applications.

Latest Patents

Hedge holds a patent for "Methods for the production of TcRγδ T cells." This patent describes a method for obtaining and expanding TcRγδ T cells in culture. The process involves culturing cells from a sample containing TcRγδ T cells or their precursors in a first culture medium that includes a T cell mitogen and at least two cytokines. Following this, the cells are cultured in a second medium that also comprises at least two cytokines. The preferred method includes specific cytokines such as interleukin-2 and interleukin-4, which are crucial for obtaining TcRγδ T cells. The cells produced through this method can be utilized in various experimental and therapeutic contexts.

Career Highlights

Hedge's career is marked by his dedication to advancing immunological research. His work at Hemosol Inc. has allowed him to focus on innovative solutions in cell therapy. With a patent portfolio that includes one significant patent, Hedge continues to contribute to the scientific community.

Collaborations

Some of Hedge's notable coworkers include David N Bell and Danna Lynn Skea. Their collaborative efforts have likely enhanced the research and development processes at Hemosol Inc.

Conclusion

Phyllis Robin Hedge is a distinguished inventor whose work in T cell production showcases his commitment to advancing medical science. His innovative methods hold promise for future applications in therapy and research.